Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Gender identity and supportive care
Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
Acute distress abuse or unsafe medication
Current suicidal intent, severe self-harm, family violence, homelessness, exploitation or complications from unregulated hormones or puberty-suppressing products requires immediate health and safeguarding action rather than waiting for a gender-service assessment.
Action: Use the relevant emergency pathway, provide supervised mental-health safety, obtain a private medicines and safeguarding history, involve paediatrics, toxicology or endocrinology when indicated, share information proportionately for protection, and maintain respectful communication throughout.
Purpose and principles
Offer respectful, exploratory and developmentally appropriate care to a young person with gender-related questions or distress, address physical and mental health without diagnostic overshadowing, assess consent and safeguarding, support family and social functioning, and use the current commissioned specialist pathway for any gender-service or medical intervention decisions.
Begin with the young person as a whole person rather than treating identity as a symptom or predetermined conclusion. Ask what they have noticed, when, in which settings, what causes comfort or distress and what help they want today. Use their requested name and pronouns in the consultation, while checking whether these are safe in records, letters, portals, school or family communication. Explain confidentiality and its limits. Allow privacy and an independent interpreter, and avoid asking intimate questions merely from curiosity; link each question to health, consent or safeguarding.
Assessment is broad and exploratory. Review childhood and current development, pubertal stage and trajectory, body distress, sexuality, relationships, menstrual or genital symptoms and any social changes already tried. Explore mood, anxiety, self-harm, suicide, eating, autism, ADHD, trauma, bullying, discrimination, online communities, family response, school attendance and support. Coexisting neurodevelopmental or mental-health needs neither invalidate gender experience nor prove that a particular intervention is appropriate. Formulate how all factors interact and treat urgent or impairing problems now.
Indications, selection and cautions
Gender-related distress
The young person describes discomfort or impairment linked to sex characteristics, social recognition or incongruence, with an individual pattern and course.
Coexisting mental-health need
Depression, anxiety, self-harm, eating difficulty, trauma or obsessive symptoms require their own assessment and timely evidence-based care.
Neurodevelopmental adjustment need
Autism, ADHD, learning difficulty or communication difference may require slower pacing, concrete information and supported decision-making without invalidating experience.
Family or social danger
Threats, rejection, bullying, forced disclosure, homelessness or coercive practices change confidentiality, safeguarding and practical support priorities.
Unregulated medicine exposure
Online or non-governed supply, uncertain product identity, absent laboratory monitoring or pressure from a provider creates medical and safeguarding risk.
Red flags requiring action
Suicidal intent, escalating self-harm, severe depression, psychosis or inability to remain safe requires direct urgent assessment irrespective of whether distress is attributed to gender.
Threats, punishment, forced concealment or disclosure, conversion attempts, eviction, bullying or online exploitation indicates safeguarding and housing risk.
Assessment before treatment
01Developmental and psychosocial assessmentFirst step
Why
Understand the young person's experience, goals, distress, functioning and interacting needs.
Interpretation and limitations
Integrate the person's narrative with development, family, school, peers, mental health and safety over time without using a questionnaire to dictate identity or treatment.
02Private mental-health and safety assessment
Why
Identify acute distress, self-harm, suicide, abuse and protective support.
Interpretation and limitations
Immediate intent or unsafe home conditions require urgent action; coexisting symptoms receive appropriate treatment and are not assumed to explain away gender experience.
03Pubertal and physical-health assessment
Why
Address growth, puberty, menstrual, genital and general medical concerns on their own merits.
Interpretation and limitations
Use consented examination and phenotype-directed tests only when clinically indicated; endocrine or gonadal pathology remains possible and should not be diagnostically overshadowed.
04Decision-specific competence assessment
Why
Determine whether the young person can make the particular healthcare decision.
Interpretation and limitations
Assess understanding, retention, weighing, voluntariness and communication after adjustments, revisiting the finding when the decision, information or developmental context changes.
Treatment approach
01Immediate careTreat urgent health and safety needsFirst stepThere is suicide risk, abuse, homelessness, severe distress or possible medicine toxicity.+
1Use emergency physical or mental-health pathways and maintain respectful name, pronoun, privacy and communication choices where safe.
2Assess privately for self-harm, family violence, bullying, exploitation and the exact source and use of any medication.
3Involve safeguarding, paediatrics, toxicology, endocrinology or emergency services proportionately and explain information sharing.
4Secure safe accommodation, supervision, treatment and follow-up without making ordinary healthcare conditional on identity decisions.
02SupportBuild an exploratory care planThe young person seeks help with gender-related questions or distress and is not in immediate danger.+
1
Complications, monitoring and follow-up
Review distress, self-harm, suicide risk, mood, eating, sleep, substance use, bullying, attendance and family or housing safety at clinically appropriate intervals.
Track whether the specialist referral is accepted, what support applies during waiting and who owns local mental and physical healthcare.
Reconfirm safe names, pronouns, phone numbers, portal access and correspondence recipients whenever home, school or relationship circumstances change.
If any hormone or suppressing product is used, reconcile product, source, dose, route, adverse symptoms and available monitoring at every review and seek current policy-based advice.
Assess growth, puberty and menstrual or genital symptoms when clinically relevant, investigating new red flags instead of attributing them automatically to gender distress.
Review family support and school adjustments, escalating threats, forced disclosure, conversion practices or homelessness through safeguarding and social support pathways.
Special situations
Respect and exploration coexist
Using requested language and listening carefully does not require predicting an outcome; it creates the safety needed for honest developmental exploration.
Treat the whole young person
Depression, asthma, pain, contraception and safeguarding need timely care even while a specialist gender referral is pending.
Policy is live information
Commissioning and prescribing rules have changed, so clinicians must check the current NHS England publication at each relevant decision.
Unregulated use needs engagement
A punitive response may drive medication underground; careful reconciliation, harm assessment and clear governance advice preserve safety.
Family work can protect connection
Even amid disagreement, shared goals around safety, communication, education and belonging can reduce crisis and homelessness risk.
Common pitfalls
01
Disclosing a requested name, pronouns, referral or identity information through unsafe letters, portals or conversations without checking consent and risk.
02
Assuming every mental or physical symptom is caused by gender distress and missing treatable illness, abuse or medication toxicity.
03
Withholding depression, sexual-health or other routine care until a specialist gender-service assessment occurs.
04
Presenting either a fixed medical pathway or a forced identity change as the expected outcome of an exploratory consultation.
05
Relying on an outdated commissioning rule instead of checking the current NHS England service specification and clinical policies.
06
Abandoning a young person who uses an unregulated product rather than assessing exposure, immediate harm, safeguarding and safe ongoing healthcare.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Paediatrics and child healthOriginal SBA
Support while awaiting specialist care
A 15-year-old describes gender-related distress and is waiting for specialist assessment. They also have worsening depression and bullying but no immediate suicide intent. What is the best local approach?
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.
NHS England unregulated provider guidanceMarch 2026 primary-care advice on governance and safety when under-18s receive hormone medicines from unregulated providers.
Supportive care includes respectful language, relief of ordinary physical symptoms, mental-health treatment when indicated, family work, school and safeguarding liaison, and practical advice about safe communication. Social choices such as clothing, hairstyle, name or pronouns may be personally important and should be discussed in context of the young person's preferences, safety and flexibility. The clinician should not impose a social transition, attempt to force identity change or present exploration as disbelief. Record the young person's own account, uncertainty and goals without pathologising language.
In England, NHS Children and Young People's Gender Services operate under a national specialist service specification and referral pathway published in April 2026. Current NHS England policy states that puberty-suppressing hormones are not routinely commissioned for gender incongruence or dysphoria. Policy for masculinising or feminising hormones has been under review, so clinicians must consult the live NHS England policy rather than rely on a memorised historical rule. Decisions about specialist gender-related medical interventions require the commissioned multidisciplinary pathway, evidence discussion, consent framework and required monitoring; they are not initiated during a routine unspecialised consultation.
Some young people may already use medicines from private or unregulated sources. Ask exactly what product, strength, route, supply, prescriber, monitoring and duration applies, and assess symptoms without threatening withdrawal of all care. NHS England advises primary care not to support unregulated-provider prescribing in specified circumstances. Seek current specialist, safeguarding, pharmacy and medical-defence advice, manage acute harm and explain clearly what can and cannot safely be done. Maintain access to general practice, sexual health, contraception, vaccination and mental-health care throughout.
Family disagreement needs skilled work. Hear the young person privately and invite carers' observations with consent or lawful justification. Focus shared discussions on keeping the young person safe, connected, in education and able to communicate rather than forcing immediate agreement on every belief. If disclosure could lead to violence, eviction or conversion practices, create a protection plan before information sharing. Review over time: identity, distress, development, family context and service policy can change, while respectful continuity itself is therapeutic.
Key points
Ask the young person which name, pronouns and terms they want used, who may know them, and which communications are safe; do not disclose identity information casually.
Offer an open exploration of experience, duration, distress, body concerns, hopes and uncertainty without steering towards a predetermined identity, social outcome or medical intervention.
Take a complete adolescent history including development, puberty, menstrual or genital symptoms, mental health, neurodevelopment, eating, substances, relationships, school, online life, bullying and safeguarding.
Treat depression, anxiety, self-harm, pain, acne, menstrual symptoms, sexual-health needs and other ordinary conditions promptly; referral to a gender service is not a reason to withhold general healthcare.
Assess decision-specific competence or capacity and family and peer influence for each care choice, using communication adjustments and private time rather than assuming autonomy or incapacity.
Support families to maintain safety, connection and respectful dialogue even when views differ; protection is required when conflict becomes abuse, coercion or threatened homelessness.
Use the current NHS Children and Young People's Gender Service referral pathway and service specification; confirm local eligibility and information requirements because commissioned pathways can change.
Medicines obtained from unregulated sources may have uncertain identity, dose and monitoring and require non-judgemental assessment of immediate adverse effects and specialist advice.
Headache, visual symptoms, chest pain, breathlessness, unilateral leg swelling, jaundice, severe mood change or injection complication during hormone exposure requires urgent medical evaluation.
Pubertal delay, rapid virilisation, galactorrhoea, growth disturbance or genital or gonadal symptoms should be investigated clinically rather than assumed to arise from gender distress.
05Medicine and provider reconciliation
Why
Identify actual exposure, governance, interactions and monitoring when products are already used.
Interpretation and limitations
Verify packaging, route, dose, prescriber, source, laboratory results and symptoms; uncertain products or adverse findings need current specialist, pharmacy or toxicology advice.
Clarify goals, language, confidentiality, body concerns, development, uncertainty, mental health, family, school and online context.
2Treat coexisting health needs and agree practical support for distress, communication, bullying, education and family relationships.
3Assess competence for each proposed action and distinguish reversible social choices from specialist medical decisions without oversimplifying impact.
4Set a review date and a safe route back because needs, identity, risk and family circumstances may evolve.
03Specialist pathwayRefer and coordinate under current policyThe young person may benefit from NHS specialist gender-service assessment or already receives related intervention.+
1Check the live national and regional referral pathway, eligibility, required information and waiting-period support before submitting the referral.
2Share a balanced developmental, physical, mental-health, neurodevelopmental, safeguarding and family summary with the young person's involvement.
3Keep primary and local services treating ordinary health needs and monitoring safety while the specialist service assesses gender-related care.
4For existing external medication, follow current NHS England unregulated-provider guidance and obtain named specialist and governance advice.
Authoring stateComplete draft
Clinical stateAwaiting review
JurisdictionUnited Kingdom
Puberty-suppressing hormones are not routinely commissioned by NHS England for gender incongruence, and non-specialists should not initiate or informally continue unregulated prescribing outside current policy and governance.
When medication has already been obtained elsewhere, do not abandon the young person: assess what was taken, adverse effects, immediate safety and safeguarding, and obtain current specialist and regulatory advice.